Tomas Salmonson, formerly occupying senior positions at the Medical Products Agency, Sweden, recently joined Pharmetheus’ Board of Directors, and we couldn’t be prouder. Tomas’ many years at the Medical Products Agency, during which he was also chair of the Committee for Medicinal Products for Human Use and of the Pharmacokinetics Working Party at the European Medicines Agency, are now being followed by a consulting journey.
Tomas shared with us: “My interest lies in advancing the field, Board work was not necessarily an objective, but if there was one to join, it was Pharmetheus’.”. We look forward to Tomas’ regulatory lens contributions to our strategies in order to realize the full potential of quantitative approaches to improve health.
